Skip to main content
  • Are We Optimizing the Use of Dual Antiplatelet Therapy in Patients Hospitalized with Acute Myocardial Infarction?

    Highlights

    • The use of DAPT after discharge increased between 2001 and 2011.
    • Very limited data is available about the trends in the use of DAPT after AMI.
    • Being male and undergoing PCI are positively associated with receiving DAPT.
    • Females, older patients, and CABG patients are not optimally managed with DAPT.

    Abstract

    Background

    Dual antiplatelet therapy (DAPT) is a mainstay treatment for hospital survivors of an acute myocardial infarction (AMI). However, there are limited data on the prescribing patterns of DAPT among patients hospitalized with AMI during recent years.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details